TIVC Valion Bio, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $28.5K and sold $0 on the open market.
TIVC revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$7.10M
- Quarter ended Mar 31, 2026: revenue n/a, net income −$6.20M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$2.85M
- Quarter ended Sep 30, 2025: revenue $146K, net income −$2.60M
Recent TIVC insider trades
- Apr 15, 2026: Bolton Sheryle bought 10,000 shares ($10.4K)
- Apr 1, 2026: Valauri Christina Rizopoulos bought 19,000 shares ($18.1K)
5%+ owners
- Murchinson Ltd.: 10.0% (Schedule 13G, filed Jul 17, 2026)
- 3i, LP: 9.9% (Schedule 13G/A, filed Sep 4, 2026)